Sanofi posts strong mid-stage results for lunsekimig in asthma and CRSwNP but a setback in atopic dermatitis clouds the ...

COPD without smoking? New data reveal unexpected symptoms and inflammation patterns. Read more to see what this means for ...

Sanofi’s lunsekimig met its endpoints in asthma and CRSwNP but missed the primary endpoint in eczema.

Kymera Therapeutics shares jump after FDA grants Fast Track to KT-621 for eosinophilic asthma, spotlighting its ...

Asthma in older age is associated with significantly higher rates of depression, cognitive decline, and multimorbidity.

Kymera Therapeutics (KYMR) stays a Strong Buy on KT-621 Phase 1b AD results, FDA Fast Track, and $1.6B cash runway—click to ...

Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP The AIRCULES phase 2b study ...

The arrival of spring in our area has brought warmer weather, blooming flowers, greener grass, and, for many, seasonal allergies. Seasonal allergies are caused by pollen produced by plants. Tree ...

The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...

Nebraska Racing Hall of Fame trainer David Anderson's horses were all listed as scratched by the stewards at Fonner Park ...

Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...

Medications used to treat osteoporosis, like risedronate and alendronate, shouldn’t be taken with coffee. “Whether it’s ...